Microbicides & their implications in HIV prevention.
作者信息
Abdool Karim Salim S, Baxter Cheryl
出版信息
Indian J Med Res. 2010 Dec;132(6):656-9.
Abstract
摘要
相似文献
1
Microbicides & their implications in HIV prevention.
Indian J Med Res. 2010 Dec;132(6):656-9.
2
A second chance for microbicides.
Lancet. 2007 Jul 7;370(9581):17-8. doi: 10.1016/S0140-6736(07)61029-0.
3
Overview of microbicides for the prevention of human immunodeficiency virus.
Best Pract Res Clin Obstet Gynaecol. 2012 Aug;26(4):427-39. doi: 10.1016/j.bpobgyn.2012.01.010. Epub 2012 Mar 2.
4
Women testing tenofovir for HIV prevention.
AIDS Patient Care STDS. 2005 Feb;19(2):128.
5
Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.
BJOG. 2014 Oct;121 Suppl 5(0 5):53-61. doi: 10.1111/1471-0528.12843.
6
The trials of tenofovir trials.
Lancet. 2005;365(9465):1111.
7
Topical microbicides for prevention of sexually transmitted infections.
Cochrane Database Syst Rev. 2012 Jun 13(6):CD007961. doi: 10.1002/14651858.CD007961.pub2.
8
Can AIDS drug also prevent HIV infection?
AIDS Read. 2004 Jan;14(1):14.
9
AIDS clinical trials. More woes for novel HIV prevention approach.
Science. 2005 Mar 18;307(5716):1708. doi: 10.1126/science.307.5716.1708a.
10
Diverse approaches useful for microbicide trials.
Nature. 2007 Sep 6;449(7158):24. doi: 10.1038/449024c.
引用本文的文献
1
Application of Dendrimers for the Treatment of Infectious Diseases.
Molecules. 2018 Aug 31;23(9):2205. doi: 10.3390/molecules23092205.
2
Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1.
Int J Nanomedicine. 2016 Apr 5;11:1281-94. doi: 10.2147/IJN.S96352. eCollection 2016.
3
Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
Int J Nanomedicine. 2014 Jul 29;9:3591-600. doi: 10.2147/IJN.S62673. eCollection 2014.
4
Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States.
Infect Dis Rep. 2011 Jan 1;3(1). doi: 10.4081/idr.2011.e6.
5
HIV: Pre-exposure Prophylaxis.
Int J Prev Med. 2012 Dec;3(12):900-1. doi: 10.4103/2008-7802.104864.
6
An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
BMC Womens Health. 2012 Nov 1;12:40. doi: 10.1186/1472-6874-12-40.
7
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.
Lancet. 2011 Jul 16;378(9787):279-81. doi: 10.1016/S0140-6736(11)60878-7.
本文引用的文献
1
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19.
2
In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
PLoS One. 2010 Feb 19;5(2):e9310. doi: 10.1371/journal.pone.0009310.
3
Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.
J Virol. 2009 Oct;83(20):10358-65. doi: 10.1128/JVI.01073-09. Epub 2009 Aug 5.
4
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
Lancet. 2008 Dec 6;372(9654):1977-87. doi: 10.1016/S0140-6736(08)61842-5.
5
Vaginal microbicides and the prevention of HIV transmission.
Lancet Infect Dis. 2008 Nov;8(11):685-97. doi: 10.1016/S1473-3099(08)70254-8.
6
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
N Engl J Med. 2008 Jul 31;359(5):463-72. doi: 10.1056/NEJMoa0707957.
7
Critical issues in mucosal immunity for HIV-1 vaccine development.
J Allergy Clin Immunol. 2008 Jul;122(1):3-9; quiz 10-1. doi: 10.1016/j.jaci.2008.03.036. Epub 2008 May 12.
8
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.
PLoS One. 2008 Jan 23;3(1):e1474. doi: 10.1371/journal.pone.0001474.
9
HIV trial doomed by design, say critics.
Nature. 2007 Jul 12;448(7150):110-1. doi: 10.1038/448110a.
10
Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
Biochem Pharmacol. 2007 Apr 1;73(7):911-22. doi: 10.1016/j.bcp.2006.09.014. Epub 2006 Sep 19.
Zotero 插件